« PPC » : différence entre les versions
aucun résumé des modifications
Aucun résumé des modifications |
Aucun résumé des modifications |
||
| Ligne 29 : | Ligne 29 : | ||
Several technological approaches oriented towards the use of clinical samples and high throughput are available, including mass spectrometry (MRM and HRMS) and ultra-sensitive immunoassays (ALAMAR NULISA, QUANTERYX SIMOA and MSD). | Several technological approaches oriented towards the use of clinical samples and high throughput are available, including mass spectrometry (MRM and HRMS) and ultra-sensitive immunoassays (ALAMAR NULISA, QUANTERYX SIMOA and MSD). | ||
Integrated in the Montpellier Proteome Cluster since its creation and IBiSA labeled, its mission is equally to make medical, biological and technical expertise in Clinical Proteomics available to academic and industrial teams. The PPC has been ISO 9001 certified since 2014 | |||
|Discipline=Sciences & Technologies | |||
|SousDisciplineSciences&Technologies=PE4 Chimie physique et analytique | |||
|Thematique=Proteomics | |||
Epitranscriptomics | |||
|TypeDonnee=Données expérimentales, Données instrumentales, Spectres masse | |||
|Communaute=Communauté scientifique montpelliéraine | |||
|Beneficiaire=Chercheurs, Enseignants-Chercheurs, Ingénieurs, Doctorants, Tout public | |||
|Science ouverte=Politique de données | |||
|Politique de données=https://doi.org/10.57745/0L8OX3 | |||
|ModeleEconomique=Prestations payantes | |||
|Certification=iso 9001 | |||
|Relation=INBS PROFI | |||
|StatutPage=Page en construction | |||
}} | |||